These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30154488)
1. Redox-responsive self-assembly PEG nanoparticle enhanced triptolide for efficient antitumor treatment. Wang Y; Liu X; Wang X; Zheng W; Zhang J; Shi F; Liu J Sci Rep; 2018 Aug; 8(1):12968. PubMed ID: 30154488 [TBL] [Abstract][Full Text] [Related]
2. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer. Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453 [TBL] [Abstract][Full Text] [Related]
3. Multiple-Coated PLGA Nanoparticles Loading Triptolide Attenuate Injury of a Cellular Model of Alzheimer's Disease. Jia L; Nie XQ; Ji HM; Yuan ZX; Li RS Biomed Res Int; 2021; 2021():8825640. PubMed ID: 33708996 [TBL] [Abstract][Full Text] [Related]
4. Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis. Zhang L; Chang J; Zhao Y; Xu H; Wang T; Li Q; Xing L; Huang J; Wang Y; Liang Q Int J Nanomedicine; 2018; 13():2051-2064. PubMed ID: 29670349 [TBL] [Abstract][Full Text] [Related]
5. ATB Lou D; Lou Z; Lin Y; Shangguan H; Lin Y; Luo Q; Zhang H; Lin G; Chen R; Kou L; Bao S Bioorg Med Chem Lett; 2021 Feb; 33():127728. PubMed ID: 33346010 [TBL] [Abstract][Full Text] [Related]
6. Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine. Wang C; Liu B; Xu X; Zhuang B; Li H; Yin J; Cong M; Xu W; Lu A Oncotarget; 2016 Feb; 7(7):8360-72. PubMed ID: 26840019 [TBL] [Abstract][Full Text] [Related]
7. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer. Wang Y; Liu T; Li H J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618 [TBL] [Abstract][Full Text] [Related]
9. Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma. Li Z; Lan J; Wu Y; Ding Y; Zhang T Drug Deliv; 2024 Dec; 31(1):2354687. PubMed ID: 38823413 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles. Xu L; Chen H; Xu H; Yang X Eur J Pharm Biopharm; 2008 Nov; 70(3):741-8. PubMed ID: 18761405 [TBL] [Abstract][Full Text] [Related]
11. Mussel-Derived, Cancer-Targeting Peptide as pH-Sensitive Prodrug Nanocarrier. Ma Y; He P; Tian X; Liu G; Zeng X; Pan G ACS Appl Mater Interfaces; 2019 Jul; 11(27):23948-23956. PubMed ID: 31192575 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel water-soluble, rapid-release triptolide prodrug with improved drug-like properties and high efficacy in human acute myeloid leukemia. Kang D; Pan X; Song Y; Liu Y; Wang D; Zhu X; Wang J; Hu L Eur J Med Chem; 2022 Dec; 243():114694. PubMed ID: 36115206 [TBL] [Abstract][Full Text] [Related]
13. Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes. Yuan ZX; Jia L; Lim LY; Lin JC; Shu G; Zhao L; Ye G; Liang XX; Ji H; Fu HL Int J Nanomedicine; 2017; 12():5673-5686. PubMed ID: 28848346 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas. Li X; Mao Y; Li K; Shi T; Yao H; Yao J; Wang S Drug Deliv; 2016 May; 23(4):1344-54. PubMed ID: 25853479 [TBL] [Abstract][Full Text] [Related]
15. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma. Ling D; Xia H; Park W; Hackett MJ; Song C; Na K; Hui KM; Hyeon T ACS Nano; 2014 Aug; 8(8):8027-39. PubMed ID: 25093274 [TBL] [Abstract][Full Text] [Related]
16. Zeng H; Zhu X; Tian Q; Yan Y; Zhang L; Yan M; Li R; Li X; Wang G; Ma J; Su Y; Zhang X; Ma L; Zhang Z; Wu X Drug Deliv; 2020 Dec; 27(1):848-854. PubMed ID: 32508161 [TBL] [Abstract][Full Text] [Related]
17. Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury. Deng X; Zeng T; Li J; Huang C; Yu M; Wang X; Tan L; Zhang M; Li A; Hu J Biomater Sci; 2019 Dec; 7(12):5312-5323. PubMed ID: 31617509 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of Triptolide-loaded pluronic P105 polymeric micelles. Li H; Wen XS; Di W Arzneimittelforschung; 2012 Jul; 62(7):340-4. PubMed ID: 22588630 [TBL] [Abstract][Full Text] [Related]
19. Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide. Cai XJ; Fei WD; Xu YY; Xu H; Yang GY; Cao JW; Ni JJ; Wang Z Drug Deliv Transl Res; 2020 Feb; 10(1):93-107. PubMed ID: 31418132 [TBL] [Abstract][Full Text] [Related]
20. Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer. Chen Y; Yang J; Wang C; Wang T; Zeng Y; Li X; Zuo Y; Chen H; Zhang C; Cao Y; Sun C; Wang M; Cao X; Ge X; Liu Y; Zhang G; Deng Y; Peng C; Lu A; Lu J J Exp Clin Cancer Res; 2024 Jul; 43(1):207. PubMed ID: 39054545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]